Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma

NIH RePORTER · NIH · R33 · $365,801 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10173926
Project number
5R33NS111058-03
Recipient
UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator
Joya Chandra
Activity code
R33
Funding institute
NIH
Fiscal year
2021
Award amount
$365,801
Award type
5
Project period
2019-05-01 → 2024-05-31